English
SlovenčinaQuality Management
The Biomedical Research Center of the Slovak Academy of Sciences (BMC SAS) is one of the top scientific institutions in the field of biomedical research in Slovakia and is constantly striving to improve the quality of its research and services.
The Biomedical Research Center of SAS (BMC SAS) is the first institution of the Slovak Academy of Sciences to implement a quality management system and has been awarded the ISO 9001:2015 certificate. This is a guarantee that BMC SAS will consistently provide products and services that meet the requirements of customers and partners, as well as the applicable regulations and regulatory requirements.
The quality management system according to the requirements of the international standard EN ISO 9001:2015 has been implemented in our institution since 2 May 2024. After a successful certification audit performed by ISOQAR SK, s.r.o., our quality management system was also approved by the international certification body Alcumus ISOQAR on 22 November 2024.
The basic principles of the quality policy applied at BMC SAS can be found here.
The quality management system implemented at BMC SAS covers activities related to research, development, design and production of biological organisms, materials, reagents, methodologies, information, technologies, intellectual property, and standards for the advancement, validation and application of scientific knowledge in the medical, natural, agricultural and veterinary sciences in order to meet the requirements of stakeholders, applicable regulatory requirements and regulatory requirements.
So far, it has been implemented in practice in four organisational units of the BMC SAS – the Institute of Virology, the Institute of Experimental Endocrinology, the Institute of Experimental Oncology and the Institute of Clinical and Translational Research, which are located at Dúbravská cesta 9, 845 05 Bratislava. This year we plan to extend it to all organisational units of BMC SAS.
Laboratory for Diagnosis and Prevention of Rickettsial and Chlamydial Infections located in the premises of the Institute of Virology BMC SAV, v.v.i. operates a biosafety level 3 facility which enables the development of experimental vaccines against coxiellosis and chlamydial infections in livestock, goats or sheep and produce diagnostic antigens or sera for the simple, rapid and reliable diagnosis of these etiological agents. Especially in the field of Q fever diagnosis, a whole range of products are available to enable a wide range of serological tests at the highest sensitivity. Our laboratory provides also advisory and technical assistance.
More information here.
Development, validation and implementation of methods for the assessment of efficacy, safety and purity of biologically active compounds in GMP certified control laboratory. Analysis and output controls of activities conducted in BTL’s R&D laboratories:
- Physical and chemical analyses
- microbiological analyses
- virological analyses
- molecular biology analyses
More information here.
